SCHEMBL13305271

SCHEMBL13305271

CCN(CC)CCCN1c2ccccc2Sc2ccc(SC)cc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 9/20 0.78
CYP2D6 P10635 9/20 0.78
ALDH1A1 P00352 3/20 0.78
KDM1A O60341 3/20 0.58
HTR1A P08908 7/20 0.54
TP53 P04637 7/20 0.54
DRD2 P14416 6/20 0.54
CHRM2 P08172 6/20 0.54
ADRA2A P08913 6/20 0.54
CHRM1 P11229 6/20 0.54
DRD1 P21728 6/20 0.54
SLC6A2 P23975 6/20 0.54
SLC6A4 P31645 6/20 0.54
ADRA1A P35348 6/20 0.54
OPRM1 P35372 6/20 0.54
DRD3 P35462 6/20 0.54
KCNH2 Q12809 6/20 0.54
CYP2C19 P33261 5/20 0.54
THPO P40225 5/20 0.54
MTOR P42345 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13305247 0.96 CYP1A2 (0.73) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
SCHEMBL29385444 0.88 CYP2D6 (1.00) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
SCHEMBL142864 0.88 CYP2D6 (1.00) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
SCHEMBL4247663 0.86 CYP1A2 (0.71) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
Chlorproethazine SCHEMBL149201 0.83 CYP1A2 (0.77) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
Chlorproethazine SCHEMBL29818123 0.83 CYP1A2 (0.77) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
SCHEMBL9678540 0.83 CYP1A2 (0.73) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
Chlorproethazine SCHEMBL9724486 0.82 LMNA (0.78) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
SCHEMBL6864995 0.82 POLB (0.68) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A
Chlorproethazine SCHEMBL1648952 0.81 CYP1A2 (0.74) CYP1A2CYP2D6ALDH1A1KDM1AHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012217-B2 Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2015-04-21 US disclosed
US-9012217-B2 Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2015-04-21 US disclosed
US-20100159596-A1 SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-06-24 US disclosed
US-20100159596-A1 SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100159596-A1 SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION RCOR3, BRD3, BRPF3 CYP1A2 2498/4885CYP2D6 1351/4885ALDH1A1 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.